CBI To Probe Ex-Assistant Drugs Controller Misconduct: High Court

New Delhi: In a significant development, the High Court of Punjab and Haryana has directed the Central Bureau of Investigation (CBI) to take over the investigation of a case involving alleged cheating by a former Assistant Drugs Controller of Himachal Pradesh, Nishant Sareen, among others.

The case came to light following allegations that the official, despite being directed by the Supreme Court to surrender to the trial court within four weeks, continued to attend office. This act of defiance raised questions about the support he might have received from the investigating agency handling the case.

The High Court’s decision was influenced by the petitioner’s counsel highlighting potential obstructions in the investigation, including the frequent reassignment of Investigating Officers, especially before court hearings. The court observed these actions as deliberate attempts to impede the judicial process.

Acknowledging the gravity of the accusations, which include complicity of police officers, the High Court deemed it necessary for an independent body like the CBI to conduct a fair and unbiased investigation.

“Taking into consideration the entire facts of the case and very serious allegations made against all the respondents including police officers, it is a fit case where the investigation has to be handed over to an independent agency like CBI for the purpose of fair and unbiased investigation,” the court noted in the order.

This order marks a pivotal move towards ensuring the integrity of the judicial system and upholding the rule of law. The CBI’s involvement is expected to bring transparency to the proceedings and address the serious allegations leveled against the respondents.

Related Posts

  • Pharma
  • May 16, 2025
  • 100 views
Trump targets Big Pharma with drug price order; Indian generics seen gaining edge

US President Donald Trump’s move to slash prescription drug prices by tying them to rates in countries such as the UK and Germany may rattle multinational pharmaceutical giants, but it…

  • Pharma
  • May 16, 2025
  • 96 views
Emcutix and Mantra Pharma Introduce Ureaderm: Advanced Urea-Based Moisturizers for Indian Skin

Emcutix Biopharmaceuticals Ltd in partnership with Canada-based Mantra Pharma Inc—both subsidiaries of Emcure Pharmaceuticals Ltd—has launched Ureaderm 10% and 20%, a new range of urea-based moisturizers designed to address severe dryness…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Trump targets Big Pharma with drug price order; Indian generics seen gaining edge

Trump targets Big Pharma with drug price order; Indian generics seen gaining edge

Emcutix and Mantra Pharma Introduce Ureaderm: Advanced Urea-Based Moisturizers for Indian Skin

Emcutix and Mantra Pharma Introduce Ureaderm: Advanced Urea-Based Moisturizers for Indian Skin

DCA seizes syrup stocks over misleading fever cure claim

DCA seizes syrup stocks over misleading fever cure claim

Mankind Pharma Faces Rs 341.86 Cr Tax Demand

Mankind Pharma Faces Rs 341.86 Cr Tax Demand

Piramal Pharma stock falls 5% after Q4 results; check key numbers here

Piramal Pharma stock falls 5% after Q4 results; check key numbers here

Biolumpivaxin: Bharat Biotech launches new vaccine against lumpy skin disease

Biolumpivaxin: Bharat Biotech launches new vaccine against lumpy skin disease